These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 6252149)
1. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Landersdorfer CB; Bulitta JB; Kinzig M; Holzgrabe U; Sörgel F Clin Pharmacokinet; 2009; 48(2):89-124. PubMed ID: 19271782 [TBL] [Abstract][Full Text] [Related]
2. Comparison of concentrations of two doses of clavulanic acid (200 and 400 milligrams) administered with amoxicillin (2,000 milligrams) in tissues of patients undergoing colorectal surgery. Martin C; Mallet MN; Sastre B; Viviand X; Martin A; De Micco P; Gouin F Antimicrob Agents Chemother; 1995 Jan; 39(1):94-8. PubMed ID: 7695337 [TBL] [Abstract][Full Text] [Related]
3. Antibiotics in the treatment of biliary infection. Dooley JS; Hamilton-Miller JM; Brumfitt W; Sherlock S Gut; 1984 Sep; 25(9):988-98. PubMed ID: 6381248 [No Abstract] [Full Text] [Related]
4. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use. Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743 [TBL] [Abstract][Full Text] [Related]
5. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862 [TBL] [Abstract][Full Text] [Related]
6. Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections. Portier H; Kazmierczak A; Lucht F; Tremeaux JC; Chavanet P; Duez JM Infection; 1985; 13 Suppl 1():S123-8. PubMed ID: 3850854 [TBL] [Abstract][Full Text] [Related]
8. Cephalosporins in the treatment of meningitis. Neu HC Drugs; 1987; 34 Suppl 2():135-53. PubMed ID: 3319497 [TBL] [Abstract][Full Text] [Related]
9. Sultamicillin in the treatment of superficial skin and soft tissue infections in children. Goldfarb J; Aronoff SC; Jaffe A; Reed MD; Blumer JL Antimicrob Agents Chemother; 1987 Apr; 31(4):663-4. PubMed ID: 3038003 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue penetration of a single dose of ornidazole (1,000 milligrams intravenously) for antibiotic prophylaxis in colorectal surgery. Martin C; Bruguerolle B; Mallet MN; Condomines M; Sastre B; Gouin F Antimicrob Agents Chemother; 1990 Oct; 34(10):1921-4. PubMed ID: 2291657 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue penetration of a single 1,000-milligram, intravenous dose of metronidazole for antibiotic prophylaxis of colorectal surgery. Martin C; Sastre B; Mallet MN; Bruguerolle B; Brun JP; De Micco P; Gouin F Antimicrob Agents Chemother; 1991 Dec; 35(12):2602-5. PubMed ID: 1810194 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tissue penetration of single-dose cefotetan used for antimicrobial prophylaxis in patients undergoing colorectal surgery. Martin C; Portet C; Lambert D; Bruguerolle B; Sastre B; De Micco P; Gouin F Antimicrob Agents Chemother; 1992 May; 36(5):1115-8. PubMed ID: 1510402 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery. Martin C; Ragni J; Lokiec F; Guillen JC; Auge A; Pecking M; Gouin F Antimicrob Agents Chemother; 1992 Dec; 36(12):2804-7. PubMed ID: 1482149 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid. Kosmidis J; Stathakis C; Mantopoulos K; Pouriezi T; Papathanassiou B; Daikos GK J Antimicrob Chemother; 1980 Sep; 6 Suppl A():147-51. PubMed ID: 6252149 [No Abstract] [Full Text] [Related]
15. Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue. Braga PC; Pozzato C; Cedrini C; Fraschini F; Scarpazza G; Scaglione F; Gagliardi V; Apicella F; Manganelli V; Paiola G Clin Ther; 1982; 5(1):69-78. PubMed ID: 6290066 [TBL] [Abstract][Full Text] [Related]
16. Levels of cefotaxime in body fluids and tissues: a review. Novick WJ Rev Infect Dis; 1982; 4 Suppl():S346-53. PubMed ID: 6294783 [TBL] [Abstract][Full Text] [Related]
17. [Availability of cefotaxime. Pharmacokinetic studies on the distribution in central and various peripheral compartments (author's transl)]. Wittmann DH; Schassan HH; Welter J; Seidel H MMW Munch Med Wochenschr; 1980 Apr; 122(17):637-41. PubMed ID: 6248774 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid. Lutsar I; Friedland IR Clin Pharmacokinet; 2000 Nov; 39(5):335-43. PubMed ID: 11108433 [TBL] [Abstract][Full Text] [Related]
19. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins. Steele RW Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182 [No Abstract] [Full Text] [Related]